SB1114 - Expanding Access to Low-Cost Generics Act of 2023
US Congress - 118th Congress
Introduced byTina Smith, Mike Braun
Last updated over 1 year ago
2 Co-Sponsors
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now